Can Sitagliptin enhance the therapeutic efficacy of GLP-1 receptor agonists when used in combination therapy?
Sunil JoshiExplorer
Can Sitagliptin improve the efficacy of GLP-1 receptor agonists in therapy?
Share
Sitagliptin, a DPP-4 inhibitor, may enhance GLP-1 levels, potentially improving the efficacy of GLP-1 receptor agonists in managing type 2 diabetes.